Precision Medicine Market Size, Share, and Analysis, By Type (Inhibitors, Monoclonal Antibodies, Cell & Gene Therapy, Antivirals, Antiretroviral), By Application (Oncology, Rare diseases, Hematology, Infectious, and Others), By Technology (Genomics, Transcriptomics and Epigenomics, and Others), By End User (Hospitals & Clinics, Home care), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2023-2032
Precision Medicine Market Size, Share, and Analysis, By Type (Inhibitors, Monoclonal Antibodies, Cell & Gene Therapy, Antivirals, Antiretroviral), By Application (Oncology, Rare diseases, Hematology, Infectious, and Others), By Technology (Genomics, Transcriptomics and Epigenomics, and Others), By End User (Hospitals & Clinics, Home care), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2023-2032
PRODUCT OVERVIEW
Precision Medicine Market is expected t%li%grow at a CAGR of 12.1% in the forecast period (2023-2032), with the market size valued at USD 39.66 billion in 2021 and projected t%li%reach USD 138.6 billion by 2032.
Precision medicine, sometimes referred t%li%as personalized medicine, is a healthcare strategy that customizes medical judgments, therapies, and treatments t%li%specific patients by considering their distinctive genetic make-up, way of life, and environmental circumstances. It has become more well-known as a result of developments in genomics, genomic sequencing technology, and data analysis, which make it possible t%li%identify genetic variations linked t%li%diseases and provide tailored treatments. Precision medicine includes diagnostic tools, biomarker testing, and the integration of complicated patient data utilizing artificial intelligence and machine learning. It is mostly prominent in oncology but is moving int%li%other medical fields. It is a dynamic and evolving industry since regulatory bodies are actively involved in forming the regulatory framework, yet issues with data privacy, standardization, and reimbursement still exist.
MARKET HIGHLIGHTS
Precision Medicine Market is expected t%li%reach USD 138.6 billion, growing at a CAGR of 12.1%. Advances in genomics and genetic sequencing technology are principally responsible for the sector of precision medicine's present remarkable expansion. These developments make it easier t%li%find the genetic differences linked t%li%diseases and t%li%provide personalized treatments after that. Precision medicine is finding uses outside of oncology, increasing demand for diagnostic equipment and biomarker testing. The precision of treatment decisions is als%li%being improved by the incorporation of substantial patient data and the use of artificial intelligence for data analysis. Precision medicine is positioned as a dynamic and promising strategy for improving patient care and outcomes thanks t%li%regulatory authorities' support and the continual evolution of guidelines.
Precision Medicine Market Segments:
Growth Drivers
Expansion of Genetic Testing and Related Procedures t%li%Boost the Market
Increasing Demand for Cell and Gene Therapies will Hasten Market Expansion
Restraint
High Cost of Therapy is Hurting the Market
Key Players
PRODUCT OVERVIEW
Precision Medicine Market is expected t%li%grow at a CAGR of 12.1% in the forecast period (2023-2032), with the market size valued at USD 39.66 billion in 2021 and projected t%li%reach USD 138.6 billion by 2032.
Precision medicine, sometimes referred t%li%as personalized medicine, is a healthcare strategy that customizes medical judgments, therapies, and treatments t%li%specific patients by considering their distinctive genetic make-up, way of life, and environmental circumstances. It has become more well-known as a result of developments in genomics, genomic sequencing technology, and data analysis, which make it possible t%li%identify genetic variations linked t%li%diseases and provide tailored treatments. Precision medicine includes diagnostic tools, biomarker testing, and the integration of complicated patient data utilizing artificial intelligence and machine learning. It is mostly prominent in oncology but is moving int%li%other medical fields. It is a dynamic and evolving industry since regulatory bodies are actively involved in forming the regulatory framework, yet issues with data privacy, standardization, and reimbursement still exist.
MARKET HIGHLIGHTS
Precision Medicine Market is expected t%li%reach USD 138.6 billion, growing at a CAGR of 12.1%. Advances in genomics and genetic sequencing technology are principally responsible for the sector of precision medicine's present remarkable expansion. These developments make it easier t%li%find the genetic differences linked t%li%diseases and t%li%provide personalized treatments after that. Precision medicine is finding uses outside of oncology, increasing demand for diagnostic equipment and biomarker testing. The precision of treatment decisions is als%li%being improved by the incorporation of substantial patient data and the use of artificial intelligence for data analysis. Precision medicine is positioned as a dynamic and promising strategy for improving patient care and outcomes thanks t%li%regulatory authorities' support and the continual evolution of guidelines.
Precision Medicine Market Segments:
- By Type
- Inhibitors
- Monoclonal Antibodies
- Cell & Gene Therapy
- Antivirals
- Antiretroviral
- By Technology
- Genomics
- Transcriptomics and Epigenomics
- Others
- By Application
- Oncology
- Rare diseases
- Haematology
- Infectious
- Others
- By End Users
- Hospitals & Clinics
- Home care
Growth Drivers
Expansion of Genetic Testing and Related Procedures t%li%Boost the Market
Increasing Demand for Cell and Gene Therapies will Hasten Market Expansion
Restraint
High Cost of Therapy is Hurting the Market
Key Players
- Illumina, Inc.
- Therm%li%Fisher Scientific, Inc.
- Roche Holding AG
- Qiagen N.V.
- Myriad Genetics, Inc.
- Exact Sciences Corporation
- Bristol-Myers Squibb
- Novartis AG
- Amgen Inc.
- AstraZeneca PLC
- Gilead Sciences, Inc.
- Bio-Rad Laboratories, Inc.
- Foundation Medicine, Inc.
- Becton, Dickinson and Company (BD)
- Tempus, Inc.
- Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight int%li%the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1.Regional Market Share
1.2. Business Trends
1.3.Precision Medicine Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Precision Medicine Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. PRECISION MEDICINE MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. PRECISION MEDICINE MARKET
10.1.Overview
10.2. Historical Analysis (2019-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.PRECISION MEDICINE MARKET SIZE & FORECAST 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Type
11.3.1.1.Inhibitors
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Monoclonal Antibodies
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Cell & Gene Therapy
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Antivirals
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5.Antiretroviral
11.3.1.5.1.By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Application
11.3.2.1.Oncology
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Rare Disease
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Hematology
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.4. Infectious
11.3.2.4.1. By Value (USD Million) 2022-2032F
11.3.2.4.2.Market Share (%) 2022-2032F
11.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.5. Others
11.3.2.5.1. By Value (USD Million) 2022-2032F
11.3.2.5.2.Market Share (%) 2022-2032F
11.3.2.5.3.Y-o-Y Growth (%) 2022-2032F
11.3.3. By Technology
11.3.3.1Genomics
11.3.3.1.1 By Value (USD Million) 2022-2032F
11.3.3.1.2Market Share (%) 2022-2032F
11.3.3.1.3Y-o-Y Growth (%) 2022-2032F
11.3.3.2Transcriptomics and Epigenomics
11.3.3.2.1By Value (USD Million) 2022-2032F
11.3.3.2.2 Market Share (%) 2022-2032F
11.3.3.3.1Y-o-Y Growth (%) 2022-2032F
11.3.3.3Others
11.3.3.3.1By Value (USD Million) 2022-2032F
11.3.4.1.2Market Share (%) 2022-2032F
11.3.4.1.3Y-o-Y Growth (%) 2022-2032F
11.3.4By End Users
11.3.4.1 Hospitals and Clinics
11.3.4.1.1 By Value (USD Million) 2022-2032F
11.3.4.1.2Market Share (%) 2022-2032F
11.3.4.1.3Y-o-Y Growth (%) 2022-2032F
11.3.4.2Homecare
11.3.4.2.1By Value (USD Million) 2022-2032F
11.3.4.2.2 Market Share (%) 2022-2032F
11.3.4.2.3 Y-o-Y Growth (%) 2022-2032F
12. NORTH AMERICA PRECISION MEDICINE MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Technology
12.3.2.By End Users
12.3.3.By Type
12.3.4.By Application
12.4. Country
12.4.1. United States
12.4.2.Canada
13. EUROPE PRECISION MEDICINE MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Technology
13.3.2.By End Users
13.3.3.By Type
13.3.4.By Application
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE & FORECAST 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Technology
14.3.2.By End Users
14.3.3.By Type
14.3.4. By Application
14.4. Country
14.4.1. India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET SIZE & FORECAST 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Technology
15.3.2.By End Users
15.3.3.By Type
15.3.4.By Application
15.4. Country
15.4.1. Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa
16. LATIN AMERICA PRECISION MEDICINE MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Technology
16.3.2.By End Users
16.3.3.By Type
16.3.4.By Application
16.4. Country
16.4.1. Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1.Illumina, Inc.
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2.Thermo Fisher Scientific, Inc.
18.3.Roche Holding AG
18.4.Qiagen N.V.
18.5.Myriad Genetics, Inc.
18.6.Exact Sciences Corporation
18.7.Bristol-Myers Squibb
18.8.Novartis AG
18.9.Amgen Inc.
18.10.AstraZeneca PLC
18.11. Gilead Sciences, Inc.
18.12.Bio-Rad Laboratories, Inc.
18.13.Foundation Medicine, Inc.
18.14.Becton, Dickinson and Company (BD)
18.15.Tempus, Inc.
18.16.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION
1.1.Regional Market Share
1.2. Business Trends
1.3.Precision Medicine Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2.Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Precision Medicine Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. PRECISION MEDICINE MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. PRECISION MEDICINE MARKET
10.1.Overview
10.2. Historical Analysis (2019-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11.PRECISION MEDICINE MARKET SIZE & FORECAST 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Type
11.3.1.1.Inhibitors
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Monoclonal Antibodies
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Cell & Gene Therapy
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Antivirals
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.5.Antiretroviral
11.3.1.5.1.By Value (USD Million) 2022-2032F
11.3.1.5.2. Market Share (%) 2022-2032F
11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Application
11.3.2.1.Oncology
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Rare Disease
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Hematology
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.4. Infectious
11.3.2.4.1. By Value (USD Million) 2022-2032F
11.3.2.4.2.Market Share (%) 2022-2032F
11.3.2.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.5. Others
11.3.2.5.1. By Value (USD Million) 2022-2032F
11.3.2.5.2.Market Share (%) 2022-2032F
11.3.2.5.3.Y-o-Y Growth (%) 2022-2032F
11.3.3. By Technology
11.3.3.1Genomics
11.3.3.1.1 By Value (USD Million) 2022-2032F
11.3.3.1.2Market Share (%) 2022-2032F
11.3.3.1.3Y-o-Y Growth (%) 2022-2032F
11.3.3.2Transcriptomics and Epigenomics
11.3.3.2.1By Value (USD Million) 2022-2032F
11.3.3.2.2 Market Share (%) 2022-2032F
11.3.3.3.1Y-o-Y Growth (%) 2022-2032F
11.3.3.3Others
11.3.3.3.1By Value (USD Million) 2022-2032F
11.3.4.1.2Market Share (%) 2022-2032F
11.3.4.1.3Y-o-Y Growth (%) 2022-2032F
11.3.4By End Users
11.3.4.1 Hospitals and Clinics
11.3.4.1.1 By Value (USD Million) 2022-2032F
11.3.4.1.2Market Share (%) 2022-2032F
11.3.4.1.3Y-o-Y Growth (%) 2022-2032F
11.3.4.2Homecare
11.3.4.2.1By Value (USD Million) 2022-2032F
11.3.4.2.2 Market Share (%) 2022-2032F
11.3.4.2.3 Y-o-Y Growth (%) 2022-2032F
12. NORTH AMERICA PRECISION MEDICINE MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Technology
12.3.2.By End Users
12.3.3.By Type
12.3.4.By Application
12.4. Country
12.4.1. United States
12.4.2.Canada
13. EUROPE PRECISION MEDICINE MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Technology
13.3.2.By End Users
13.3.3.By Type
13.3.4.By Application
13.4. Country
13.4.1.Germany
13.4.2.United Kingdom
13.4.3.France
13.4.4. Italy
13.4.5.Spain
13.4.6.Russia
13.4.7.Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. ASIA-PACIFIC PRECISION MEDICINE MARKET SIZE & FORECAST 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Technology
14.3.2.By End Users
14.3.3.By Type
14.3.4. By Application
14.4. Country
14.4.1. India
14.4.2.China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET SIZE & FORECAST 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Technology
15.3.2.By End Users
15.3.3.By Type
15.3.4.By Application
15.4. Country
15.4.1. Israel
15.4.2.GCC
15.4.3.North Africa
15.4.4. South Africa
15.4.5.Rest of Middle East and Africa
16. LATIN AMERICA PRECISION MEDICINE MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Technology
16.3.2.By End Users
16.3.3.By Type
16.3.4.By Application
16.4. Country
16.4.1. Mexico
16.4.2.Brazil
16.4.3.Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1.Illumina, Inc.
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2.Thermo Fisher Scientific, Inc.
18.3.Roche Holding AG
18.4.Qiagen N.V.
18.5.Myriad Genetics, Inc.
18.6.Exact Sciences Corporation
18.7.Bristol-Myers Squibb
18.8.Novartis AG
18.9.Amgen Inc.
18.10.AstraZeneca PLC
18.11. Gilead Sciences, Inc.
18.12.Bio-Rad Laboratories, Inc.
18.13.Foundation Medicine, Inc.
18.14.Becton, Dickinson and Company (BD)
18.15.Tempus, Inc.
18.16.Other Prominent Players
19. APPENDIX
20.CONSULTANT RECOMMENDATION